Medical News
Impact on Antimicrobial Consumption of Procalcitonin-Guided...
Ann Intensive Care.
The use of PCT values to guide therapy, in comparison to the use of clinical, biological (apart from PCT) and...
14 Oct 2021
Nephrotoxicity of Continuous Amphotericin B in Critically Il...
J Antimicrob Chemother.
CCAB with TDM did not result in renal impairment over time in critically ill patients with abdominal sepsis.
07 Oct 2021
Short versus Prolonged Courses of Antimicrobial Therapy for...
J. Antimicrob. Chemother.
Short-course antimicrobial therapy could be as effective as prolonged-course therapy for uncomplicated P....
04 Oct 2021
Prognostic Factors for Late Death in Septic Shock Survivors:...
Intern Emerg Med.
Independent risk factors for late death on multivariate regression analysis were age; malignancy; and hemoglobin,...
04 Oct 2021
eCMEs
Key Trials
Pharmacokinetics and Pharmacodynamics of Imipenem by Two-Step and Extended Infusions in Sepsis Patients
The pharmacokinetic/pharmacodynamic (PK/PD) parameters achieved in two-step and extended regimens of imipenem were comparable in the treatment of...
Benefits of Inhaled Budesonide in Early COVID-19 Infection: STOIC Study
This infographic summarises the key points of the STOIC study and outlines the benefits of administering inhaled budesonide in early COVID-19...
Utility of C-Reactive Protein Based Protocol in the Duration of Antibiotic Therapy in Critically Ill Patients
A protocol based on daily monitoring of C-reactive protein levels may allow early interruption of antibiotic therapy in a higher proportion of...
Novel Antibiotic Adjuvant Entity Might Be an Effective Empirical Therapy for Treating Nosocomial Infections
It can be concluded that the use of CSE 1034 of ceftriaxone, sulbactam, and ethylenediaminetetraacetic acid is an effective option for the treatment...
Slide Library
Cefuroxime (Novacef)
Cefuroxime is a second-generation cephalosporin antibiotic. It is a broad-spectrum antibacterial agent with a favorable pharmacokinetic profile....
Management of Mucormycosis in ENT Practice
Mucormycosis are the group of invasive infection caused by filamentous fungi of the Mucoraceae family. This slide set enumerates prevalence,...
Antifungal Therapy in Immunocompromised Patients
Early initiation of antifungal therapy is a major contributor to enhanced survival rate. This set of slides highlights incidence and risk factors of...
Disseminated Tuberculosis with ARDS
Disseminated TB results from widespread blood borne dissemination of TB bacilli. This presentation includes causes and risk factors of disseminated...
Our Publications
Ronapreve (Casirivimab and Imdevimab) Monograph
Casirivimab and imdevimab are human, non-competing, high-affinity, IgG1 (immunoglobulin G1)-neutralising monoclonal antibodies produced by...
Cytorx (Flucytosine) Monograph
This monograph describes the role of Flucytosine tablets in the management of invasive cryptococcal infections and some Candida spp. infections.
Clarithromycin: An Emerging Treatment Recourse in Lower Respiratory Tract Infections
Parenteral macrolide therapy is needed for patients with moderate to severe CAP/AECB. This booklet gives an overview of the efficacy and safety of...
MRSA: The Clinician’s Challenge
The article summarizes the Indian epidemiological data for MRSA infections, along with treatment of MRSA infections and infection control measures.
Poll
Do you perceive any clinical benefits of neurotrophic agent in the management of acute brain injury?
Yes
Sometimes
No
Total votes: 12